In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist

In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist

Solid rationales are still present for the identification of synthetic ligands to simultaneously target multiple PPAR subtypes for the treatment of T2DM. The purpose of this study was to characterize the in vitro and in vivo differential effects of chiglitazar, a non-TZD type of PPAR pan-agonist cur...

Full description

Saved in:
Bibliographic Details
Main Authors: B. K. He, Z. Q. Ning, Z. B. Li, S. Shan, D. S. Pan, B. C. B. Ko, P. P. Li, Z. F. Shen, G. F. Dou, B. L. Zhang, X. P. Lu, Y. Gao
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2012/546548
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items